More Press Releases

View Older Stories View Newer Stories

May 21, 2024 02:00AM Progress on share buyback programme
May 21, 2024 02:00AM
May 21, 2024 02:00AM Transaction in Own Shares
May 21, 2024 02:00AM Subsea7 share repurchases
May 21, 2024 01:45AM The European Union needs to implement new standards for personal image protection says Robert Szustkowski
May 21, 2024 01:45AM SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test
May 21, 2024 01:42AM Akastor ASA: DRU arbitration award - Settlement of interest and costs
May 21, 2024 01:05AM BW LPG Limited - Notice of Annual General Meeting 2024
May 21, 2024 01:30AM KKR Invests in Healthcare Revenue Solutions Provider Infinx
May 21, 2024 01:30AM Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
May 21, 2024 01:30AM BGHL (GBP): NAV(s)
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:30AM BGHL (EUR): NAV(s)
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:20AM Cantargia Publishes Interim Report for the First Quarter of 2024
May 21, 2024 01:18AM Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
May 21, 2024 01:04AM FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
May 21, 2024 01:10AM Presto Automation Announces Fiscal Third Quarter 2024 Financial Results
May 21, 2024 01:32AM
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:30AM Nextensa : RESULTS ON Q1 2024
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:20AM IRLAB Presents at ABGSC Investor Days
May 21, 2024 01:10AM Litchfield Hills Research reiterates buy recommendation at $10.00 per share
May 21, 2024 01:00AM Innate Pharma: Clarification Regarding SAR443579 Designation
May 21, 2024 01:00AM Elliptic Labs Shipping AI Virtual Smart Sensor on vivo’s Y200 Smartphone
May 21, 2024 01:00AM Stephen van Rooyen Appointed Chief Executive Officer of VodafoneZiggo
May 21, 2024 01:00AM BW LPG Limited - Notice of Scheme meeting regarding redomiciling to Singapore
May 21, 2024 01:00AM DNO to Hold Fixed Income Investor Meetings   
May 21, 2024 01:00AM Idorsia announces changes to Idorsia Executive Committee and Board of Directors
May 21, 2024 01:00AM Start of Day Message
May 21, 2024 01:00AM FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
May 21, 2024 01:00AM Planisware - Q1 2024 revenue - Strong start of the year and dynamic commercial momentum
May 21, 2024 01:00AM Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
View Newer Stories View Older Stories